Your browser doesn't support javascript.
loading
Nafamostat Reduces the Incidence of post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Horváth, István László; Kleiner, Dénes; Nagy, Rita; Fehérvári, Péter; Hankó, Balázs; Hegyi, Péter; Csupor, Dezso.
Affiliation
  • Horváth IL; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Kleiner D; University Pharmacy, Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.
  • Nagy R; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Fehérvári P; University Pharmacy, Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.
  • Hankó B; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
  • Hegyi P; Heim Pál National Pediatric Institute, Budapest, Hungary.
  • Csupor D; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Clin Pharmacol Ther ; 115(2): 206-212, 2024 02.
Article in En | MEDLINE | ID: mdl-38032816

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatitis / Benzamidines / Cholangiopancreatography, Endoscopic Retrograde / Guanidines Type of study: Systematic_reviews Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatitis / Benzamidines / Cholangiopancreatography, Endoscopic Retrograde / Guanidines Type of study: Systematic_reviews Limits: Adult / Humans Language: En Journal: Clin Pharmacol Ther Year: 2024 Document type: Article Affiliation country: